Discover the full management transaction log of 경동제약, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 경동제약 has published 62 public disclosures. Market capitalisation: €146.7bn. The latest transaction was disclosed on 4 March 2026 (Purchase). Among the most active insiders: 류덕희. All data is openly available.
62
Insider Decl.
0
Thresholds
€3,540
46 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Buys €3,540· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
